Publications by authors named "Lorena Mora"

Claim this Profile
I
Incidence, Clinical Features and Vaccination Coverage of Pneumococcal Disease in People Living with HIV: A Retrospective Cohort Study (2015-2024).
Pere Medina, Elisa de Lazzari, Mateu Espasa, Lorena de la Mora, María Martínez-Rebollar

Vaccines (Basel)· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Role of Protease Inhibitors in HIV Treatment: Who Still Needs Them in 2025?
Abiu Sempere, Rodrigo Alonso, Leire Berrocal, Julia Calvo, Alberto Foncillas, Lorena de la Mora

Infect Dis Ther· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advanced HIV Disease in the ICU: Experience from a Spanish Cohort.
Esther Martinez, Alberto Foncillas, Lorena De la Mora, Josep Mallolas, Jose M Miro

Clin Infect Dis· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Health Outcomes of People with HIV Engaged in Chemsex: A Prospective Cohort Study on Drug Use, Sexual Behaviour, Sexually-Transmitted Infections and Vulnerability.
Lorena De La Mora, Montserrat Laguno, Berta Torres, Ivan Chivite, Alberto Foncillas, Rubén Mora

Infect Dis Ther· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacogenetics and Molecular Ancestry of , , , , , , and in Ecuadorian Subjects with Type 2 Diabetes Mellitus.
Adiel Ortega-Ayala, Carla González de la Cruz, Lorena Mora, Mauro Bonilla, Leandro Tana

Pharmaceuticals (Basel)· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidemiological changes and outcomes of people living with HIV admitted to the intensive care unit: a 14-year retrospective study.
Esther Martínez, Alberto Foncillas, Adrián Téllez, Sara Fernández, Gemma Martínez-Nadal, Lorena De la Mora

Infection· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence, risk factors and the impact of tenofovir treatment in SARS-CoV-2 infection and COVID-19 disease among people living with HIV: A cross-sectional population-based study.
Elisa de Lazzari, Daniel K Nomah, Jose L Blanco, Naira Rico, Xabier Filella, Lorena de la Mora

Int J Infect Dis· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Burden of liver steatosis and liver fibrosis in a large cohort of people living with HIV.
Montserrat Laguno, Elisa de Lazzari, Leire Berrocal, Alexy Inciarte, Maria Martínez-Rebollar, Lorena de la Mora

HIV Med· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid initiation of bictegravir/emtricitabine/tenofovir alafenamide as first-line therapy in HIV infection. A prospective study.
Ainoa Ugarte, Lorena De La Mora, Elisa De Lazzari, Iván Chivite, Emma Fernández

J Antimicrob Chemother· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness, safety and discontinuation rates of bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) in people with HIV using real-world data: a systematic review and meta-analysis.
Iván Chivite, Leire Berrocal, Elisa de Lazzari, Soodabeh Navadeh, Carla Lluis-Ganella, Lorena de la Mora

J Antimicrob Chemother· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidemiology, treatment and prognosis of HIV infection in 2024: A practical review.
Lorena de la Mora, Josep Mallolas, Juan Ambrosioni

Med Clin (Barc)· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolving AIDS- and non-AIDS Mortality and Predictors in the PISCIS Cohort of People Living With HIV in Catalonia and the Balearic Islands (Spain), 1998-2020.
Daniel K Nomah, Suju Jamarkattel, Andreu Bruguera, Sergio Moreno-Fornés, Yesika Díaz, Lorena de la Mora

Open Forum Infect Dis· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toxic-Induced Encephalopathy Following Chemsex in a Young HIV-Positive Male: A Complex Case of Acute Cognitive Impairment with Anterograde Amnesia and Behavioral Alterations.
Alexy Inciarte, Lorena de la Mora, Emilio Huaier-Arriazu, Berta Torres, Silvia Cañizares, Elizabeth Zamora

Infect Dis Ther· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of raltegravir plus lamivudine maintenance therapy.
Beatriz Borjabad, Alexy Inciarte, Ivan Chivite, Ana Gonzalez-Cordon, Mar Mosquera, Lorena De La Mora

J Antimicrob Chemother· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tolerability of bictegravir/tenofovir alafenamide/emtricitabine versus dolutegravir/lamivudine as maintenance therapy in a real-life setting.
Alba Rocabert, Beatriz Borjabad, Leire Berrocal, Jordi Blanch, Alexy Inciarte, Lorena De La Mora

J Antimicrob Chemother· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical use and effectiveness of dolutegravir and lamivudine: a long-term, real-world, retrospective study.
Adrián Martínez-Serra, Elisa De Lazzari, Leire Berrocal, Alberto Foncillas, Lorena De La Mora

J Antimicrob Chemother· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increasing of New CA-MRSA Infections Detected in people living with HIV Who Engage in Chemsex in Barcelona: An Ambispective Study.
Lorena De La Mora, Cristina Pitart, Laura Morata, Ainoa Ugarte, María Martinez-Rebollar

Infect Dis Ther· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate for Nonoccupational HIV-1 Postexposure Prophylaxis: A Prospective Open-Label Trial (DORAVIPEP).
Alexy Inciarte, Ainoa Ugarte, María Martínez-Rebollar, Berta Torres, Emma Fernández, Lorena De la Mora

Open Forum Infect Dis· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perception of quality of care using patient reported experience measures (PREMs) in a cohort of adults with HIV: A cross-sectional study.
Elisa de Lazzari, Leire Berrocal, Emma Fernández, Montserrat Laguno, Iván Chivite, Lorena de la Mora

Medicine (Baltimore)· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sex-based epidemiological and immunovirological characteristics of people living with HIV in current follow-up at a tertiary hospital: a comparative retrospective study, Catalonia, Spain, 1982 to 2020.
Sara Toyos, Leire Berrocal, Ana González-Cordón, Alexy Inciarte, Lorena de la Mora

Euro Surveill· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolution of Risk Behaviors, Sexually Transmitted Infections and PrEP Care Continuum in a Hospital-Based PrEP Program in Barcelona, Spain: A Descriptive Study of the First 2 Years' Experience.
Ainoa Ugarte, Lorena de la Mora, David García, María Martínez-Rebollar, Elisa de Lazzari

Infect Dis Ther· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PrEP program experience in a hospital HIV unit. Description of baseline user profile and identification of opportunities for improvement.
Montserrat Laguno, Ainoa Ugarte, María Martinez-Rebollar, Yeray Sobrino, Guillermo Font, Lorena de la Mora

Enferm Infecc Microbiol Clin (Engl Ed)· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemsex Practices in PrEP: Beyond Addiction and Risk Toward a Healthy Sex Life-Baseline Experiences from a Hospital-Based PrEP Program in Barcelona, Spain.
Lorena De La Mora, Ainoa Ugarte, Maria Martínez-Rebollar, Elisa De Lazzari, David García-Hernández

AIDS Behav· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Do ART and Chemsex Drugs Get Along? Potential Drug-Drug Interactions in a Cohort of People Living with HIV Who Engaged in Chemsex: A Retrospective Observational Study.
Lorena De La Mora, María J Nebot, Maria Martinez-Rebollar, Elisa De Lazzari, Montserrat Tuset

Infect Dis Ther· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Barriers and facilitators to cervical cancer screening among under-screened women in Cuenca, Ecuador: the perspectives of women and health professionals.
Bernardo Vega Crespo, Vivian Alejandra Neira, José Ortíz Segarra, Andrés Andrade, Gabriela Guerra, Lorena Mora

BMC Public Health· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis